Cholinergic input to the supraoptic nucleus increases Fos expression and body temperature in rats.
To examine the role played by cholinergic input and processes in the supraoptic nucleus (SON) in the control of body temperature and water intake in rats, we used microdialysis to stimulate and analyze SON without disturbing the behavior of unanesthetized rats. After microdialysis, we also investigated immunoreactivity for c-Fos protein in the brain as an index of neuronal activation. Stimulation with neostigmine, an acetylcholine esterase inhibitor, through the microdialysis probe increased the extracellular concentration of acetylcholine in the SON. This cholinergic stimulation dose-dependently increased body temperature but did not significantly change the water intake. The stimulation markedly increased c-Fos-like immunoreactivity (Fos-IR) in the SON and certain hypothalamic areas, including the paraventricular nucleus (PVN) and median preoptic nucleus (MnPO). Fos-IR was also evident in certain regions of the pons and brainstem, including the locus ceruleus (LC), area postrema (AP), and nucleus of the solitary tract (NTS). Addition of atropine, a muscarinic receptor antagonist, to the dialysis medium containing neostigmine attenuated the increase of Fos-IR and suppressed the neostigmine-induced responses in body temperature. These results suggest that cholinergic input and activation of the muscarinic cholinoceptive neurons in the SON contribute to the regulation of body temperature. Activation of noradrenergic pathways in the brainstem including LC and NTS may be involved in the thermoregulation mechanism.
Takahashi
A
A
Tsumura Research Institute, Tsumura & Co, Ibaraki, Japan. takahashi_akira@mail.tsumura.co.jp
Ishimaru
H
H
Ikarashi
Y
Y
Kishi
E
E
Maruyama
Y
Y
D000818:Animals; D001831:Body Temperature / Q000187:drug effects / Q000502:physiology*; D001933:Brain Stem / Q000378:metabolism; D002799:Cholinergic Fibers / Q000737:chemistry / Q000378:metabolism*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004326:Drinking / Q000187:drug effects / Q000502:physiology; D008297:Male; D017551:Microdialysis; D009388:Neostigmine / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism; D011301:Preoptic Area / Q000378:metabolism; D016760:Proto-Oncogene Proteins c-fos / Q000032:analysis / Q000096:biosynthesis*; D051381:Rats; D017208:Rats, Wistar; D013495:Supraoptic Nucleus / Q000187:drug effects / Q000378:metabolism*
D002800:Cholinesterase Inhibitors; D016760:Proto-Oncogene Proteins c-fos; D009388:Neostigmine; D009638:Norepinephrine